ClinicalTrials.gov
ClinicalTrials.gov Menu

Lower-Cost Contingency Management in a Group Setting - 1

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00249600
Recruitment Status : Completed
First Posted : November 7, 2005
Last Update Posted : November 21, 2011
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
UConn Health

Brief Summary:
The purpose of this study is to evaluate the efficacy of prize contingency management (CM) in enhancing attendance, reducing drug use, and improving health among clients attending two HIV drop-in centers. Specifically, 172 clients are randomly assigned to one of two 6-month treatment conditions: standard 12-step oriented group treatment, or CM group treatment. In the CM group, clients earn the chance to win prizes for submitting clean urine specimens and for complying with steps toward their treatment goals. Activities related to improving health will be emphasized, such as attending medical appointments, recording daily medication consumption, getting prescriptions filled, and attending medication adherence support groups. Group attendance, drug use, medical problems, services received, and risky drug use and sexual behaviors will be measured pre-treatment and at months 1, 3, 6, 9 and 12.

Condition or disease Intervention/treatment Phase
Substance Abuse Behavioral: Contingency management Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 172 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Lower-Cost Contingency Management in a Group Setting
Study Start Date : March 2003
Actual Primary Completion Date : December 2007
Actual Study Completion Date : December 2007



Primary Outcome Measures :
  1. Drug use [ Time Frame: baseline and each follow-up ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria:

  • HIV-positive and a member of The Living Center or the Manchester Area Network on AIDS
  • DSM-IV diagnosis of current opioid or cocaine abuse or dependence
  • willingness to accept random assignment to one of the two treatment groups

Exclusion criteria:

  • inability to comprehend the study (Mini-mental status score <21; Folstein & Folstein, 1975; or inability to pass an informed consent quiz)
  • severely disruptive behavior
  • in recovery for pathological gambling (due to potential similarity between the CM procedure and gambling)
  • non-English speaking

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00249600


Locations
United States, Connecticut
University of Connecticut Health Center
Farmington, Connecticut, United States, 06030 2103
Sponsors and Collaborators
UConn Health
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Nancy Petry, Ph.D. UConn Health

Responsible Party: UConn Health
ClinicalTrials.gov Identifier: NCT00249600     History of Changes
Other Study ID Numbers: NIDA-14618-1
R01DA014618 ( U.S. NIH Grant/Contract )
R01-14618-1
First Posted: November 7, 2005    Key Record Dates
Last Update Posted: November 21, 2011
Last Verified: November 2011

Keywords provided by UConn Health:
contingency management
substance abuse

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders